Dr. Jelena Arambašić Jovanović

Education:
• 2011: PhD, Faculty of Biology, University of Belgrade
Thesis title: "Molecular mechanism of induction of haptoglobin gene expression in rat liver cells during experimentaly induced diabetes"
• 2003: BSc, study program: molecular biology and physiology (9.11/10), Faculty of Biology, University of Belgrade

Research title:
• 2022: Principal Research Fellow
• 2017: Senior Research Associate
• 2012: Research Associate
• 2008: Research Assistant
• 2003: Research Collaborator in the Department of Molecular Biology of IBISS

Research interest:
• The study of diabetes, the most common chronic disease today, with a special interest in integrative and nutritional therapies for the prevention and treatment of diabetes and diabetes-related complications; Examining the role of epigenetic mechanisms that influence the change in the identity of pancreatic endocrine cells using a synthetic epigenetic tool (modified CRISPR/dCas9 system) in order to reprogram pancreatic alpha cells into beta-like cells that have the ability to produce and secrete insulin, which in the future may represent a new platform for clinical use in diabetes therapy.

Participation in projects:
• National projects: The IBISS work program financed by the Ministry of Science, Technological Development and Innovation, Republic of Serbia, broj ugovora 451-03-47/2023-01/ 200007 (2023-); , broj ugovora 451-03-9/2021-14/200007 (2020-2022); OI173020 of the Ministry of Research and Technological Development, Republic of Serbia (2011 - 2019); OI143002B of the Ministry of Science and Environmental Protection, Republic of Serbia (2006 - 2010); OI1722 of the Ministry of Science, Technology and Development, Republic of Serbia ( (2001 - 2005).
• International projects and collaborations: Bilateral project between Montenegro and Serbia (2016 - 2018); Project of 7th Framework Programme of European Commission, No. 603629-ENV-2013-6.2.1-Globaqua (2014 - 2019); Participation and coordination of international cooperation with dr. Tomasz Jurkowski, Institute for Biochemistry, University of Stuttgart, Germany („Transdifferentiation of pancreatic alpha to beta cells via targeted epigenome editing using Epi-CRISPRs directed DNA methylation", European Foundation for the Study of Diabetes-EFSD); COST: Epigenetics - Bench to Bedside (TD0905, 2010-2014).

Memberships in scientific societies:
• Serbian Society for Molecular Biology
• Serbian Biochemical Society
• Serbian Biological Society